News | March 22, 2012

Infraredx TVC Intravascular Imaging System Highlighted at ACC

March 22, 2012 — Infraredx Inc. announced that its TVC Imaging System for the true vessel characterization of coronary artery disease will be featured in 11 oral and poster presentations, including a panel during the Cardiovascular Innovations Educational Forum, at the American College of Cardiology (ACC) Annual Scientific Session held March 24-27, 2012, in Chicago.

The TVC Imaging System is an intravascular imaging system aids management of coronary artery disease by providing information that is critical for evaluating vessel structure and composition. The system’s improved image resolution delivers better clinical detail, providing more reliable vessel interpretation and assessment. The device is the only multimodality imaging system to combine both intravascular ultrasound (IVUS) and near-infrared spectroscopy (NIRS).

“We are pleased to present important new information on the TVC Imaging System at the ACC.12 meeting,” said James E. Muller, M.D., founder, chairman and chief medical officer of Infraredx. “Our IVUS image provides a high quality view of structures – vessel diameter, stent expansion – and our NIR data, obtained in the same pullback, provides accurate, automated detection of lipid core plaque. New data to be presented show that the versatile spectroscopy method can identify cap thickness as well as lipid core detection, and a comparison with non-invasive CTA shows the potential of CTA to serve as a screening tool for lipid core plaque. A potential screening strategy employing new technology will be featured in a special session in the Exposition Hall.”

The company will be exhibiting at booth #3054. The technology will also be discussed in several sessions. The schedule of oral and poster presentations at ACC.12 and ACC-i2 with TCT, including a panel during the Cardiovascular Innovations Educational Forum, is as follows:

Cardiovascular Innovations Educational Forum

On Sunday, March 25 at 3:55 p.m., Muller will discuss the TVC Imaging System in a presentation titled “The Role of Invasive Imaging with IVUS, NIR, and OCT to Confirm the Presence of Vulnerable Plaques” during the panel discussion “The Role of Innovative Technologies in a Novel Strategy to Prevent First Coronary Event.” The panel, which is part of the Cardiovascular Innovations Educational Forum, will be held in Hall A2 of the CV Theater.

Case Sessions

On Saturday, March 24 from 2-5 p.m., the TVC Imaging System will be a subject of discussion during the “Live and Taped Case Session I: Multivessel PCI- Physiology and Imaging” session, being held during the i2 Live and Taped Cases (Session #2201) in Hall B of the ACC.12 Main Tent.

The session will be chaired by Gary S. Mintz, M.D., chief medical officer, Cardiovascular Research Foundation. Mintz will give a presentation titled “The Exploding World of Intravascular Imaging: IVUS, OCT, NIRS, etc - Practical Use during PCI” (Presentation #2201-13) from 3:45 to 4 p.m.

Emmanouil S. Brilakis, M.D., Ph.D., director, cardiac catheterization laboratories, VA North Texas Health Care System, and associate professor of medicine, The University of Texas Southwestern Medical Center at Dallas, will present a taped case utilizing the TVC Imaging System from the University of Texas Southwestern Medical Center (Presentation #2201-15) from 4:15 to 5 p.m.

For more information:

Related Content

Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Overlay Init